Skip to content
★ Sign in to follow
RC

Roy C. Hardiman

Executive
Alumis Inc.Principia Biopharma Inc.
Insider activity · 24 months0 buys2 salesCumulative net flow
Total declarations
24
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€1.2M

Latest filing published 04 Nov 2026 for ALUMIS INC., €3,805.

Filing timeline

BuySale
Roy C. Hardiman

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

Roy C. Hardiman: trading record in brief

Filings by Roy C. Hardiman span 2 companies, the busiest being Principia Biopharma Inc. and Alumis Inc. We count 24 filings; the first trade dates from 13 December 2019 and the latest from 2 November 2026.

Every open-market trade on record is a sale: 11 sales worth €1.2M. Outside the open market, there are 3 share grants and 6 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

On 4 November 2026 came the latest disclosure, an open-market sale for €3,805 in Alumis Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Roy C. Hardiman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations